S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13
S&P 500   4,538.43
DOW   34,580.08
QQQ   383.13

Bruker Stock Forecast, Price & News

-2.28 (-2.80%)
(As of 12/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
1.45 million shs
Average Volume
1.84 million shs
Market Capitalization
$11.99 billion
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive BRKR News and Ratings via Email

Sign-up to receive the latest news and ratings for Bruker and its competitors with MarketBeat's FREE daily newsletter.

Bruker logo

About Bruker

Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the following segments: Bruker Scientific Instruments (BSI) Life Science, BSI Nano, and Bruker Energy and Supercon Technologies (BEST). The BSI Life Science segment includes enabling life science tools based on magnetic resonance technology. The BSI Nano segment offers x-ray instruments that use electromagnetic radiation with wavelengths to determine the characteristics of matter and the three-dimensional (3D) structure of molecules. The BEST segment consists of conducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research, and other applications. The company was founded by Gunther Laukien in 1960 and is headquartered in Billerica, MA.


Here's Why You Should Invest In Bruker (BRKR) Stock for Now
November 30, 2021 |  finance.yahoo.com
See More Headlines

Industry, Sector and Symbol

Analytical instruments
Life Sciences Tools & Services
Current Symbol
Year Founded

Sales & Book Value

Annual Sales
$1.99 billion
Cash Flow
$1.83 per share
Book Value
$7.18 per share


Net Income
$157.80 million
Pretax Margin




Free Float
Market Cap
$11.99 billion

Company Calendar

Last Earnings
Dividend Payable
Fiscal Year End
Next Earnings (Estimated)

Social Links


Overall MarketRank

2.64 out of 5 stars

Computer And Technology Sector

108th out of 890 stocks

Analytical Instruments Industry

2nd out of 33 stocks

Analyst Opinion: 1.3Community Rank: 4.3Dividend Strength: 1.7Insider Behavior: 4.2Valuation: 1.9 5 -4 -3 -2 -1 -

Bruker (NASDAQ:BRKR) Frequently Asked Questions

Is Bruker a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bruker in the last twelve months. There are currently 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Bruker stock.
View analyst ratings for Bruker
or view top-rated stocks.

How has Bruker's stock been impacted by Coronavirus?

Bruker's stock was trading at $40.00 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, BRKR stock has increased by 97.6% and is now trading at $79.04.
View which stocks have been most impacted by COVID-19

When is Bruker's next earnings date?

Bruker is scheduled to release its next quarterly earnings announcement on Tuesday, February 15th 2022.
View our earnings forecast for Bruker

How were Bruker's earnings last quarter?

Bruker Co. (NASDAQ:BRKR) announced its quarterly earnings data on Monday, November, 1st. The medical research company reported $0.63 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.44 by $0.19. The medical research company had revenue of $608.90 million for the quarter, compared to analyst estimates of $575.33 million. Bruker had a trailing twelve-month return on equity of 31.48% and a net margin of 11.44%. The company's revenue for the quarter was up 19.1% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.42 EPS.
View Bruker's earnings history

How often does Bruker pay dividends? What is the dividend yield for Bruker?

Bruker declared a quarterly dividend on Monday, November 15th. Stockholders of record on Wednesday, December 1st will be paid a dividend of $0.04 per share on Friday, December 17th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.20%. The ex-dividend date is Tuesday, November 30th.
View Bruker's dividend history

Is Bruker a good dividend stock?

Bruker pays an annual dividend of $0.16 per share and currently has a dividend yield of 0.20%. The dividend payout ratio of Bruker is 9.04%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Bruker will have a dividend payout ratio of 7.02% next year. This indicates that Bruker will be able to sustain or increase its dividend.
View Bruker's dividend history.

What guidance has Bruker issued on next quarter's earnings?

Bruker issued an update on its FY 2021 earnings guidance on Monday, November, 8th. The company provided earnings per share (EPS) guidance of $2.050-$2.090 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.930. The company issued revenue guidance of $2.38 billion-$2.40 billion, compared to the consensus revenue estimate of $2.36 billion.

What price target have analysts set for BRKR?

6 analysts have issued twelve-month price objectives for Bruker's stock. Their forecasts range from $57.00 to $100.00. On average, they expect Bruker's stock price to reach $78.86 in the next year. This suggests that the stock has a possible downside of 0.2%.
View analysts' price targets for Bruker
or view top-rated stocks among Wall Street analysts.

Who are Bruker's key executives?

Bruker's management team includes the following people:
  • Frank H. Laukien, Chairman, President & Chief Executive Officer (LinkedIn Profile)
  • Gerald N. Herman, Chief Financial Officer & Executive Vice President
  • Mark Robert Munch, Executive Vice President
  • Jürgen Srega, Group President-Bruker CALID Segment
  • Falko Busse, President-Bruker BioSpin Group

What is Frank H. Laukien's approval rating as Bruker's CEO?

75 employees have rated Bruker CEO Frank H. Laukien on Glassdoor.com. Frank H. Laukien has an approval rating of 54% among Bruker's employees. This puts Frank H. Laukien in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Bruker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bruker investors own include AbbVie (ABBV), CVS Health (CVS), Micron Technology (MU), Cisco Systems (CSCO), Intel (INTC), Alibaba Group (BABA), Walt Disney (DIS), Applied Materials (AMAT), Bank of America (BAC) and Bristol-Myers Squibb (BMY).

What is Bruker's stock symbol?

Bruker trades on the NASDAQ under the ticker symbol "BRKR."

Who are Bruker's major shareholders?

Bruker's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (4.31%), Alliancebernstein L.P. (2.17%), Fuller & Thaler Asset Management Inc. (1.34%), Arrowstreet Capital Limited Partnership (1.29%), Invesco Ltd. (1.23%) and Janus Henderson Group PLC (1.14%). Company insiders that own Bruker stock include Cynthia M Friend, Frank H Laukien and Marc A Kastner.
View institutional ownership trends for Bruker

Which institutional investors are selling Bruker stock?

BRKR stock was sold by a variety of institutional investors in the last quarter, including Invesco Ltd., Boston Trust Walden Corp, Epoch Investment Partners Inc., Credit Suisse AG, Janus Henderson Group PLC, Sector Gamma AS, GSA Capital Partners LLP, and Cubist Systematic Strategies LLC. Company insiders that have sold Bruker company stock in the last year include Cynthia M Friend, Frank H Laukien, and Marc A Kastner.
View insider buying and selling activity for Bruker
or view top insider-selling stocks.

Which institutional investors are buying Bruker stock?

BRKR stock was acquired by a variety of institutional investors in the last quarter, including Two Sigma Advisers LP, Ceredex Value Advisors LLC, Massachusetts Financial Services Co. MA, Arrowstreet Capital Limited Partnership, Goldman Sachs Group Inc., Two Sigma Investments LP, Alliancebernstein L.P., and Fuller & Thaler Asset Management Inc..
View insider buying and selling activity for Bruker
or or view top insider-buying stocks.

How do I buy shares of Bruker?

Shares of BRKR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Bruker's stock price today?

One share of BRKR stock can currently be purchased for approximately $79.04.

How much money does Bruker make?

Bruker has a market capitalization of $11.99 billion and generates $1.99 billion in revenue each year. The medical research company earns $157.80 million in net income (profit) each year or $1.77 on an earnings per share basis.

How many employees does Bruker have?

Bruker employs 7,400 workers across the globe.

Does Bruker have any subsidiaries?

The following companies are subsidiares of Bruker: Accel Instruments, Advances Diagnostic Solutions Pty. Ltd., Agapetus GmbH, Alicona Corporation, Alicona GmbH, Alicona Imaging, Alicona Imaging GmbH, Alicona Korea Pcific Ltd., Alicona Manufacturing Inc., Alicona SARL, Alicona UK Limited, Alicona s.r.l., Anasys Instruments Corporation, Anasys Instruments GmbH, Arxspan, Biocentra AS., Bruker (Beijing) Scientific Technology Co. Ltd., Bruker (Malaysia) SDN BHD, Bruker AXS GmbH, Bruker AXS Handheld Inc., Bruker AXS LLC, Bruker AXS Ltd., Bruker Advanced Supercon GmbH, Bruker Austria GmbH, Bruker Belgium S.A./N.V., Bruker BioSciences Securities Corporation, Bruker BioSpin AG, Bruker BioSpin Corporation, Bruker BioSpin GmbH, Bruker BioSpin K.K., Bruker BioSpin MRI GmbH, Bruker Business Support Center sp. z o.o, Bruker Daltonics GmbH, Bruker Daltonics Ltd., Bruker Daltonics Pty. Ltd., Bruker Daltonics S.r.l., Bruker Daltonik GmbH, Bruker Detection Corporation, Bruker EAS GmbH, Bruker Energy & Supercon Technologies Inc. , Bruker Espanola S.A., Bruker Finance B.V., Bruker France S.AS., Bruker HTS GmbH, Bruker India Scientific PVT Ltd., Bruker Invest AG, Bruker Italia S.r.l., Bruker JV Israel Ltd., Bruker JV UK Ltd., Bruker Korea Co. Ltd., Bruker Ltd., Bruker Mexicana S.A. de C.V., Bruker MicroCT N.V., Bruker Nano GmbH, Bruker Nano Inc., Bruker Nederland B.V., Bruker Nordic AB, Bruker OST LLC, Bruker Optics GmbH, Bruker Optics Inc. , Bruker Optik GmbH, Bruker PTY Ltd., Bruker Physik GmbH, Bruker Polska Sp. Z o.o., Bruker Portugal Unipessoal LDA, Bruker Scientific Instruments Hong Kong Co. Ltd., Bruker Scientific Israel Ltd., Bruker Scientific LLC, Bruker Singapore Pte. Ltd., Bruker South Africa (Pty) Ltd., Bruker Taiwan Co. Ltd., Bruker Turkey Teknolojik Sistemler Ticaret Ltd. Sirketi, Bruker UK Ltd., Bruker do Brasil Ltda., Bruker s.r.o., Hain LifeScience E.A. Ltd., Hain LifeScience GmbH, Hain LifeScience Solutions (Pty) Ltd., Hain LifeScience Spain S.L., Hain LifeScience UK Ltd., Hain LifeSciences S.A. Pty Ltd., Hydrostatic Extrusions Ltd., Hysitron, InCoaTec GmbH, InVivo Biotech Services GmbH, InVivo Biotech Svs GmbH, JPK Instruments Limited, JPK Instruments USA. Inc., JPK In­stru­ments, JUWE Laborgeraete, Jordan Valley Semiconductors, Keymaster Technologies, Luxendo, Luxendo GmbH, MAC Science, Merlin Diagnostika GmbH, Mestrelab Research S.L., Michrom Bioresources, Oncovision - Innovative Medical Imaging, PMOD Technologies, Prairie Technologies, Princeton Gamma-Tech Instruments Inc, Quantron, RI Research Instruments GmbH, Roentec AG, S.I.S. Surface Imaging Systems, SAS Biocentric, SCiLS GmbH, SkyScan, Socabim, VACUUMSCHMELZE GmbH & Co. KG, Vutara LLC, XGLabs S.r.l., and Yingsheng Technology.

When was Bruker founded?

Bruker was founded in 1960.

What is Bruker's official website?

The official website for Bruker is www.bruker.com.

Where are Bruker's headquarters?

Bruker is headquartered at 40 Manning Road, Billerica MA, 01821.

How can I contact Bruker?

Bruker's mailing address is 40 Manning Road, Billerica MA, 01821. The medical research company can be reached via phone at (978) 663-3660, via email at [email protected], or via fax at 978-663-5585.

This page was last updated on 12/4/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.